JP2000506862A - 医薬としての新規な架橋環状アミノ酸 - Google Patents
医薬としての新規な架橋環状アミノ酸Info
- Publication number
- JP2000506862A JP2000506862A JP9532604A JP53260497A JP2000506862A JP 2000506862 A JP2000506862 A JP 2000506862A JP 9532604 A JP9532604 A JP 9532604A JP 53260497 A JP53260497 A JP 53260497A JP 2000506862 A JP2000506862 A JP 2000506862A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- integer
- effective amount
- therapeutically effective
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/28—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and containing rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/46—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing nine carbon atoms
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.式 [式中、Aは、 (ここで、 R1およびR2は、それぞれ別個に水素およびメチルから選択され; R3およびR4は、それぞれ別個に水素またはメチルから選択され; nは、1から4までの整数であり;そして mは、0から2までの整数である) から選択される架橋環基である] の化合物、その薬学的に受容できる塩またはそのプロドラッグ。 2.式 [式中、Aは、 (ここで、 nは、1から4までの整数であり;そして mは、0から2までの整数である) から選択される架橋環基である] の化合物またはその薬学的に受容できる塩。 3.Aが (ここで、nは1から4までの整数であり、そして mは0から2までの整数である) である、請求項1に記載の化合物。 4.nが3であり、そして mが1である、請求項3に記載の化合物。 5.Aが (ここで、nは1から4までの整数である)である、請求項1に記載の化合物 。 6.nが1である、請求項5に記載の化合物。 7.Aが (ここで、nは1から4までの整数である)である、請求項1に記載の化合物 。 8.nが1である、請求項7に記載の化合物。 9.Aが (ここで、nは1から4までの整数である)である、請求項1に記載の化合物 。 10.nが2である、請求項9に記載の化合物。 11.Aが である、請求項8に記載の化合物。 12.(2−アミノメチル−ビシクロ[2.2.1]ヘプタ−2−イル)−酢酸メチル− エステル一塩酸塩、 [2−(アセチルアミノ−メチル)−ビシクロ[2.2.1]ヘプタ−2−イル] −酢酸、および [2−(2−アミノメチル−ビシクロ[2.2.1]ヘプタ−2−イル)−アセチ ルアミノ]−酢酸一塩酸塩 から選択される、請求項1に記載の化合物。 13.治療上有効量の請求項1に記載の化合物および薬学的に受容できるキャリヤ ーより成る薬剤組成物。 14.てんかんの治療の必要な哺乳動物に治療上有効量の請求項1に記載の化合物 を投与することより成る、てんかんの治療法。 15.失神発作、運動機能減少症、および頭蓋障害の治療の必要な哺乳動物に治療 上有効量の請求項1に記載の化合物を投与することより成る、前記疾患の治療法 。 16.神経変性疾患の治療の必要な哺乳動物に治療上有効量の請求項1に記載の化 合物を投与することより成る、神経変性疾患の治療法。 17.うつ病の治療の必要な哺乳動物に治療上有効量の請求項1に記載の化合物を 投与することより成る、うつ病の治療法。 18.不安症の治療の必要な哺乳動物に治療上有効量の請求項1に記載の化 合物を投与することより成る、不安症の治療法。 19.パニック障害の治療の必要な哺乳動物に治療上有効量の請求項1に記載の化 合物を投与することより成る、パニック障害の治療法。 20.疼痛の治療の必要な哺乳動物に治療上有効量の請求項1に記載の化合物を投 与することより成る、疼痛の治療法。 21.神経病理学的疾患の治療の必要な哺乳動物に治療上有効量の請求項1に記載 の化合物を投与することより成る、神経病理学的疾患の治療法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1343396P | 1996-03-14 | 1996-03-14 | |
US60/013,433 | 1996-03-14 | ||
PCT/US1997/002401 WO1997033859A1 (en) | 1996-03-14 | 1997-02-18 | Novel bridged cyclic amino acids as pharmaceutical agents |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2000506862A true JP2000506862A (ja) | 2000-06-06 |
Family
ID=21759944
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9532604A Ceased JP2000506862A (ja) | 1996-03-14 | 1997-02-18 | 医薬としての新規な架橋環状アミノ酸 |
Country Status (18)
Country | Link |
---|---|
US (1) | US6020370A (ja) |
EP (1) | EP0888285B1 (ja) |
JP (1) | JP2000506862A (ja) |
KR (1) | KR100487032B1 (ja) |
AT (1) | ATE210629T1 (ja) |
AU (1) | AU731279B2 (ja) |
BR (1) | BR9708180A (ja) |
CZ (1) | CZ287598A3 (ja) |
DE (1) | DE69709070T2 (ja) |
EA (1) | EA001214B1 (ja) |
ES (1) | ES2169848T3 (ja) |
IL (1) | IL125364A0 (ja) |
NO (1) | NO984204D0 (ja) |
NZ (1) | NZ331142A (ja) |
PL (1) | PL185990B1 (ja) |
SK (1) | SK282848B6 (ja) |
WO (1) | WO1997033859A1 (ja) |
ZA (1) | ZA972199B (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010084798A1 (ja) * | 2009-01-21 | 2010-07-29 | 第一三共株式会社 | 3環性化合物 |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL189872B1 (pl) | 1996-07-24 | 2005-10-31 | Warner Lambert Co | Zastosowanie izobutylogaby i jej pochodnych do wytwarzania leku do leczenia bólu |
BR9812351A (pt) | 1997-09-18 | 2000-09-19 | Warner Lambert Co | Novo processo estereoseletivo para a preparação de análogas gabapentinas |
US6984659B2 (en) | 1997-11-18 | 2006-01-10 | Klinikum Der Albert-Ludwigs Universitaet | 2-pyrrolidinone derivatives substituted at position 4 for reducing the extracellular glutamate level |
DE19751062A1 (de) * | 1997-11-18 | 1999-07-08 | Univ Ludwigs Albert | An 4-Stellung substituierte 2-Pyrrolidinon-Derivate zur Verringerung des extrazellulären Glutamat-Spiegels |
DE69826151T2 (de) * | 1997-12-16 | 2005-01-27 | Warner-Lambert Co. Llc | 1-substituierte-1-aminomethyl-cycloalkan derivate (= gabapentin analoga), deren herstellung und deren verwendung bei der behandlung von neurologischen erkrankungen |
AU757445B2 (en) * | 1998-05-26 | 2003-02-20 | Warner-Lambert Company | Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel |
ES2230863T3 (es) * | 1998-07-09 | 2005-05-01 | Warner-Lambert Company Llc | Composicion farmaceutica que contiene analogos de gaba y un agente antivirico para el tratamiento del herpres zoster. |
US6310098B1 (en) | 1999-07-22 | 2001-10-30 | University Of Rochester | Method of treating symptoms of hormonal variation, including hot flashes |
EP1267896A1 (en) * | 2000-03-28 | 2003-01-02 | Robert J. Delorenzo | Inhibition of a novel calcium injury current that forms in neurons during injury prevents neuronal cell death |
EP1296671B1 (en) * | 2000-06-26 | 2008-03-26 | Warner-Lambert Company LLC | Gabapentin analogues for sleep disorders |
EP1343805A4 (en) | 2000-10-06 | 2005-07-20 | Xenoport Inc | COMPOUNDS DERIVED FROM GALLENIC ACIDS FOR THE PROVISION OF CONTINUING SYSTEMIC CONCENTRATIONS OF MEDICINAL PRODUCTS AFTER ORAL ADMINISTRATION |
AU2002230398A1 (en) | 2000-10-06 | 2002-04-29 | Xenoport, Inc. | Bile-acid conjugates for providing sustained systemic concentrations of drugs |
MXPA03009532A (es) * | 2001-04-19 | 2004-02-12 | Warner Lambert Co | Aminoacidos biciclicos o triciclicos condensados. |
GB2374595A (en) * | 2001-04-19 | 2002-10-23 | Warner Lambert Co | Fused bicyclic or tricyclic amino acids |
US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US7232924B2 (en) * | 2001-06-11 | 2007-06-19 | Xenoport, Inc. | Methods for synthesis of acyloxyalkyl derivatives of GABA analogs |
HUP0400167A3 (en) * | 2001-06-11 | 2012-09-28 | Xenoport Inc | Prodrugs of gaba analogs, compositions and uses thereof |
US6818787B2 (en) | 2001-06-11 | 2004-11-16 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US7186855B2 (en) | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
JP2005501013A (ja) * | 2001-06-11 | 2005-01-13 | ゼノポート,インコーポレイテッド | Gaba類似体の全身濃度が持続するアミノ酸コンジュゲート |
EP1485082A4 (en) | 2002-02-19 | 2009-12-30 | Xenoport Inc | PROCESS FOR THE SYNTHESIS OF PROMEDICAMENTS FROM 1-ACYL-ALKYL DERIVATIVES AND CORRESPONDING COMPOSITIONS |
AU2003222033A1 (en) | 2002-03-20 | 2003-10-08 | Xenoport | Cyclic 1-(acyloxy)-alkyl prodrugs of gaba analogs, compositions and uses thereof |
WO2003094842A2 (en) * | 2002-05-07 | 2003-11-20 | A & D Bioscience, Inc. | Conjugates comprising central nervous system active drug |
WO2003099338A2 (en) * | 2002-05-17 | 2003-12-04 | Xenoport, Inc. | Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
US20040162351A1 (en) * | 2002-12-11 | 2004-08-19 | Gallop Mark A. | Orally administered dosage forms of fused GABA analog prodrugs having reduced toxicity |
WO2004052360A1 (en) | 2002-12-11 | 2004-06-24 | Xenoport, Inc. | Prodrugs of fused gaba analogs, pharmaceutical compositions and uses thereof |
NZ567457A (en) | 2002-12-13 | 2009-08-28 | Warner Lambert Co | Alpha-2-delta ligand to treat lower urinary tract symptoms |
CA2451267A1 (en) | 2002-12-13 | 2004-06-13 | Warner-Lambert Company Llc | Pharmaceutical uses for alpha2delta ligands |
WO2004089289A2 (en) * | 2003-03-31 | 2004-10-21 | Xenoport, Inc. | Treating or preventing hot flashes using prodrugs of gaba analogs |
EP1670451A4 (en) | 2003-09-11 | 2009-10-21 | Xenoport Inc | TREATMENT AND / OR PREVENTION OF URINARY INCONTINENCE AND PROMOTERS OF GABA ANALOGS |
WO2005025675A1 (en) | 2003-09-12 | 2005-03-24 | Pfizer Limited | Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline re-uptake inhibitors |
SG146643A1 (en) | 2003-09-17 | 2008-10-30 | Xenoport Inc | Treating or preventing restless legs syndrome using prodrugs of gaba analogs |
SG147437A1 (en) | 2003-10-14 | 2008-11-28 | Xenoport Inc | Crystalline form of gamma-aminobutyric acid analog |
AU2004305563C1 (en) | 2003-12-11 | 2011-07-07 | Sunovion Pharmaceuticals Inc. | Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression |
BRPI0517227B8 (pt) | 2004-11-04 | 2021-05-25 | Xenoport Inc | comprimido oral de liberação prolongada do ácido 1-{[alfa-isobutanoiloxietoxi)carbonil]amino metil}-1-cicloexano acético, e, uso do comprimido |
US8067402B2 (en) * | 2005-12-12 | 2011-11-29 | Allaccem, Inc. | Methods and systems for coating an oral surface |
US7727978B2 (en) | 2006-08-24 | 2010-06-01 | Bristol-Myers Squibb Company | Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors |
CA2672044A1 (en) * | 2006-12-08 | 2008-06-19 | Xenoport, Inc. | Use of prodrugs of gaba analogs for treating diseases |
RS51940B (en) | 2006-12-22 | 2012-02-29 | Recordati Ireland Limited | Combined TH2δ LIGANAD THERAPY AND NSAID FOR LOWER URINARY TRACT DISORDERS |
WO2008103847A2 (en) | 2007-02-21 | 2008-08-28 | Allaccem, Incorporated | Bridged polycyclic compound based compositions for the inhibition and amelioration of disease |
US20090041806A1 (en) * | 2007-06-15 | 2009-02-12 | Xenoport, Inc. | Use of prodrugs of gaba analogs, antispasticity agents, and prodrugs of gaba b receptor agonists for treating spasticity |
US8153617B2 (en) * | 2007-08-10 | 2012-04-10 | Allaccem, Inc. | Bridged polycyclic compound based compositions for coating oral surfaces in humans |
US8153618B2 (en) * | 2007-08-10 | 2012-04-10 | Allaccem, Inc. | Bridged polycyclic compound based compositions for topical applications for pets |
US8188068B2 (en) * | 2007-08-10 | 2012-05-29 | Allaccem, Inc. | Bridged polycyclic compound based compositions for coating oral surfaces in pets |
US8119658B2 (en) | 2007-10-01 | 2012-02-21 | Bristol-Myers Squibb Company | Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors |
TW200936123A (en) * | 2007-11-06 | 2009-09-01 | Xenoport Inc | Use of prodrugs of GABAb agonists for treating neuropathic and musculoskeletal pain |
EP2250148B1 (en) | 2008-01-25 | 2016-08-17 | XenoPort, Inc. | Crystalline form of calcium-salts of (3s)-aminomethyl-5-methyl-hexanoic acids and methods of use |
US7868043B2 (en) | 2008-01-25 | 2011-01-11 | Xenoport, Inc. | Mesophasic forms of (3S)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use |
JP5291123B2 (ja) * | 2008-01-25 | 2013-09-18 | ゼノポート,インコーポレイティド | (3s)−アミノメチル−5−ヘキサン酸プロドラッグの結晶形態及びその使用 |
EP2322499A4 (en) * | 2008-08-07 | 2011-12-21 | Kyorin Seiyaku Kk | PROCESS FOR PRODUCING A BICYCLOÝ2.2.2¨OCTYLAMINE DERIVATIVE |
ES2589915T3 (es) | 2008-10-08 | 2016-11-17 | Xgene Pharmaceutical Inc | Conjugados de GABA y métodos de utilización de los mismos |
US20110124705A1 (en) * | 2009-11-24 | 2011-05-26 | Xenoport, Inc. | Prodrugs of alpha-2-delta ligands, pharmaceutical compositions and uses thereof |
US20110130454A1 (en) * | 2009-11-24 | 2011-06-02 | Xenoport, Inc. | Prodrugs of gamma-amino acid, alpha-2-delta ligands, pharmaceutical compositions and uses thereof |
US9066853B2 (en) | 2013-01-15 | 2015-06-30 | Warsaw Orthopedic, Inc. | Clonidine compounds in a biodegradable fiber |
CA2903000C (en) | 2013-01-28 | 2021-10-12 | Hector L. Lopez | Methods of improving tolerability, pharmacodynamics, and efficacy of .beta.-alanine and use therefor |
AU2019271799B2 (en) | 2018-05-14 | 2023-10-12 | Xgene Pharmaceutical Inc. | Crystalline forms of 1-(acyloxy)-alkyl carbamate drug conjugates of naproxen and pregabalin |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3743742A (en) * | 1969-06-17 | 1973-07-03 | Merck & Co Inc | Producing anti-fibrinolytic activity with aminobicycloacetic acid derivatives |
US3641129A (en) * | 1969-06-17 | 1972-02-08 | Merck & Co Inc | Antifibrinolytic compounds |
YU36150B (en) * | 1974-11-22 | 1982-02-25 | Pliva Zagreb | Process for preparing alpha-amino-1-adamantyl acetic acid |
US4087544A (en) * | 1974-12-21 | 1978-05-02 | Warner-Lambert Company | Treatment of cranial dysfunctions using novel cyclic amino acids |
DE2543821C2 (de) * | 1974-12-21 | 1984-10-18 | Gödecke AG, 1000 Berlin | Bestimmte Salze und Ester von 1-Aminomethyl-1-cycloalkanessigsäuren und diese Verbindungen enthaltende Arzneimittel |
DE2460891C2 (de) * | 1974-12-21 | 1982-09-23 | Gödecke AG, 1000 Berlin | 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
-
1997
- 1997-02-18 CZ CZ982875A patent/CZ287598A3/cs unknown
- 1997-02-18 KR KR10-1998-0707228A patent/KR100487032B1/ko not_active IP Right Cessation
- 1997-02-18 NZ NZ331142A patent/NZ331142A/en unknown
- 1997-02-18 JP JP9532604A patent/JP2000506862A/ja not_active Ceased
- 1997-02-18 WO PCT/US1997/002401 patent/WO1997033859A1/en not_active Application Discontinuation
- 1997-02-18 AT AT97906630T patent/ATE210629T1/de not_active IP Right Cessation
- 1997-02-18 IL IL12536497A patent/IL125364A0/xx not_active IP Right Cessation
- 1997-02-18 EA EA199800797A patent/EA001214B1/ru unknown
- 1997-02-18 SK SK1248-98A patent/SK282848B6/sk unknown
- 1997-02-18 PL PL97328800A patent/PL185990B1/pl not_active IP Right Cessation
- 1997-02-18 EP EP97906630A patent/EP0888285B1/en not_active Expired - Lifetime
- 1997-02-18 US US09/068,861 patent/US6020370A/en not_active Expired - Fee Related
- 1997-02-18 DE DE69709070T patent/DE69709070T2/de not_active Expired - Fee Related
- 1997-02-18 AU AU21271/97A patent/AU731279B2/en not_active Ceased
- 1997-02-18 ES ES97906630T patent/ES2169848T3/es not_active Expired - Lifetime
- 1997-02-18 BR BR9708180A patent/BR9708180A/pt not_active IP Right Cessation
- 1997-03-13 ZA ZA9702199A patent/ZA972199B/xx unknown
-
1998
- 1998-09-11 NO NO984204A patent/NO984204D0/no not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010084798A1 (ja) * | 2009-01-21 | 2010-07-29 | 第一三共株式会社 | 3環性化合物 |
Also Published As
Publication number | Publication date |
---|---|
IL125364A0 (en) | 1999-03-12 |
NO984204L (no) | 1998-09-11 |
BR9708180A (pt) | 1999-07-27 |
NO984204D0 (no) | 1998-09-11 |
PL185990B1 (pl) | 2003-09-30 |
ATE210629T1 (de) | 2001-12-15 |
DE69709070T2 (de) | 2002-06-20 |
WO1997033859A1 (en) | 1997-09-18 |
SK124898A3 (en) | 1999-02-11 |
SK282848B6 (sk) | 2002-12-03 |
EA001214B1 (ru) | 2000-12-25 |
PL328800A1 (en) | 1999-02-15 |
KR19990087755A (ko) | 1999-12-27 |
NZ331142A (en) | 2001-04-27 |
EP0888285B1 (en) | 2001-12-12 |
ZA972199B (en) | 1997-09-17 |
EP0888285A1 (en) | 1999-01-07 |
ES2169848T3 (es) | 2002-07-16 |
KR100487032B1 (ko) | 2005-12-21 |
EA199800797A1 (ru) | 1999-04-29 |
US6020370A (en) | 2000-02-01 |
DE69709070D1 (de) | 2002-01-24 |
AU731279B2 (en) | 2001-03-29 |
CZ287598A3 (cs) | 1999-02-17 |
AU2127197A (en) | 1997-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2000506862A (ja) | 医薬としての新規な架橋環状アミノ酸 | |
KR100589066B1 (ko) | 약제로서 유용한 시클릭 아미노산 및 그의 유도체 | |
KR100512506B1 (ko) | 제약제제로서신규한치환시클릭아미노산 | |
AU759619B2 (en) | Novel amines as pharmaceutical agents | |
JP2000511877A (ja) | 医薬としての新規な環状アミノ酸 | |
JP2002508362A (ja) | 1−置換−1−アミノメチル−シクロアルカン誘導体(=ガバペンチン類縁体)、その製造および神経学的疾患の治療におけるその使用 | |
JP2002508352A (ja) | 4(3)置換−4(3)−アミノメチル−(チオ)ピラン又はピペリジン誘導体(=ガバペンチン類似体)、それらの製法および神経病理学的疾患の治療における使用 | |
JP2002516312A (ja) | カルシウムチャンネルのα2δサブユニットに対する親和性を有する立体配座的に制約されたアミノ酸化合物 | |
JP2003500486A (ja) | 3−ヘテロアリールアルキル置換gaba類似体 | |
CA2245647C (en) | Novel bridged cyclic amino acids as pharmaceutical agents | |
PT888285E (pt) | Novos amino acidos ciclicos em ponte como agentes farmaceuticos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040218 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070821 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20070814 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20071120 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080111 |
|
A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20080417 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20080527 |